IP Library Granted Patent US 8,697,055
Granted Patent B2
US 8,697,055 · App. 13/423,852 · Granted Apr 15, 2014

Probiotic, lactic acid-producing bacteria

Inventor: Sean Farmer (Miami, FL)
Assignee: Ganeden Biotech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,055
App. No.
13/423,852
Granted
Apr 15, 2014
Kind
B2
Abstract

The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-producing bacteria, preferably strains of Bacillus coagulans , for the control of gastrointestinal tract pathogens, including antibiotic-resistant gastrointestinal tract pathogens, and their associated diseases by both a reduction in the rate of colonization and the severity of the deleterious physiological effects of the colonization of the antibiotic-resistant pathogen.

Claims (24)

1. A composition comprising an isolated Bacillus coagulans bacterium and tea.

2. The composition of claim 1 , wherein said isolated Bacillus coagulans is Bacillus coagulans hammer strain Accession No. ATCC 31284.

3. The composition of claim 1 , wherein said isolated Bacillus coagulans is in the form of a spore.

4. The composition of claim 3 , wherein said Bacillus coagulans spore germinates upon contacting hot water.

5. The composition of claim 1 , wherein said isolated Bacillus coagulans is in the form of a vegetative cell.

6. The composition of claim 1 , wherein said isolated Bacillus coagulans is in the form of a combination of vegetative cells and spores.

7. The composition of claim 1 , wherein said composition is a dry or lyophilized composition.

8. The composition of claim 1 , wherein said tea comprises a tea bag.

9. A composition comprising an isolated Bacillus coagulans bacterium and coffee.

10. The composition of claim 9 , wherein said composition is freeze dried coffee or ground coffee.

11. The composition of claim 9 , wherein said isolated Bacillus coagulans is in the form of a spore.

12. The composition of claim 11 , wherein said Bacillus coagulans spore germinates upon contacting hot water.

13. The composition of claim 9 , wherein said isolated Bacillus coagulans is Bacillus coagulans hammer strain Accession No. ATCC 31284.

14. The composition of claim 9 , wherein said isolated Bacillus coagulans is in the form of a vegetative cell.

15. The composition of claim 9 , wherein said isolated Bacillus coagulans is in the form of a combination of vegetative cells and spores.

16. The composition of claim 9 , wherein said composition is a dry or lyophilized composition.

17. A composition comprising an isolated Bacillus coagulans bacterium in the form of a spore or a vegetative cell and a cereal.

18. The composition of claim 17 , wherein said cereal comprises a hot cereal.

19. The composition of claim 18 , wherein said hot cereal comprises oatmeal or Cream of Wheat®.

20. The composition of claim 17 , wherein said isolated Bacillus coagulans is in the form of a spore.

21. The composition of claim 20 , wherein said Bacillus coagulans spore germinates upon contacting hot water.

22. The composition of claim 17 , wherein said isolated Bacillus coagulans is Bacillus coagulans hammer strain Accession No. ATCC 31284.

23. The composition of claim 17 , wherein said isolated Bacillus coagulans is in the form of a vegetative cell.

24. The composition of claim 17 , wherein said isolated Bacillus coagulans is in the form of a combination of vegetative cells and spores.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 12, 2017
From: SILICON VALLEY BANK
To: GANEDEN BIOTECH, INC.
Reel/Frame 043822/0897 →
SECURITY AGREEMENT Recorded Jul 31, 2013
From: GANEDEN BIOTECH, INC.
To: SILICON VALLEY BANK
Reel/Frame 030922/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2012
From: FARMER, SEAN
To: GANEDEN BIOTECH, INCORPORATED
Reel/Frame 027917/0052 →
Continuity (7)
Continuation 12897604 · Oct 4, 2010
Continuation 12148965 · Apr 23, 2008
Continuation 11305507 · Dec 16, 2005
Continuation 10264745 · Oct 4, 2002
Continuation 09370793 · Aug 5, 1999
Provisional Application 60097594 · Aug 24, 1998
Related Publication 20120177620A1 · Jul 12, 2012